CLAIM CARD
Within the corpus, the mortality and survival outcome class shows a profile dominated by null findings for CGM-derived glucose variability metrics. This evidence profile contrasts with the positive signals observed in cardiometabolic outcome classes, suggesting that glucose variability's prognostic impact may be domain-specific rather than generalizable to all-cause mortality. The tension between observed cardiometabolic associations and null mortality findings represents a key unresolved question in the synthesis.
Evidence grade: exploratory
Contradiction status: none
Publication: becb4785-6244-41cd-ba08-c47e58dca346
Provenance: Derivation Web chain
Citation Support
source_1Sidki 2026source_2Gravesteijn 2023source_3Lu 2021source_4Lee 2020source_5Franceschi 2026